4 ms·

All of the mentioned actors are egotistical sociopaths in your example, as the EU is not talking about equitable access, only access for its own citizens. If y

All of the mentioned actors are egotistical sociopaths in your example, as the EU is not talking about equitable access, only access for its own citizens. If you care about equitable access you should be praising the UK, and in particular Oxford, for making its vaccine available at cost, and for having dedicated supply chains already established for poorer nations. There's still plenty to criticise, but the current framing demonstrates the egocentrism of all of the actors.

mpweiher 6y ago
Hmm...the EU has exported 50% of its vaccine production. The UK: 0% The US: 0% until a few days ago.
- hef19898 6y ago
  And ordered 100% more than needed for the EU in order to supply other nations with that. The UK did the same so.
  - mpweiher 6y ago
    Except that the EU isn't getting the doses it ordered, and the shortfall is significant, and it has actually exported a significant chunk. Whereas the UK is getting the doses it ordered, at the EU's expense, and has not actually exported any. So. Not exactly the same.
    - _benedict 6y ago
      The U.K. is also experiencing a significant shortfall in doses compared to those that were projected to be delivered by AZ. Production yields have been lower across the board according to Oxford researchers involved in the scale up, and several delivery milestones were missed for the U.K.
- _benedict 6y ago
  This is a very narrow view. The U.K. has made sure there are international supply chains to distribute the Oxford vaccine, and far more of that is being supplied internationally than the entirety of doses exported from the EU. I think your 50% figure is also too high, though it is a high proportion, but these doses are primarily going to wealthy countries. If the EU were asking for U.K. doses to be routed to other (particularly poorer) countries I would be sympathetic to the position, but this spat is about getting the EU doses, not about equitable access.

mpweiher 6y ago

Hmm...the EU has exported 50% of its vaccine production. The UK: 0% The US: 0% until a few days ago.

hef19898 6y ago
And ordered 100% more than needed for the EU in order to supply other nations with that. The UK did the same so.
- mpweiher 6y ago
  Except that the EU isn't getting the doses it ordered, and the shortfall is significant, and it has actually exported a significant chunk. Whereas the UK is getting the doses it ordered, at the EU's expense, and has not actually exported any. So. Not exactly the same.
  - _benedict 6y ago
    The U.K. is also experiencing a significant shortfall in doses compared to those that were projected to be delivered by AZ. Production yields have been lower across the board according to Oxford researchers involved in the scale up, and several delivery milestones were missed for the U.K.
_benedict 6y ago
This is a very narrow view. The U.K. has made sure there are international supply chains to distribute the Oxford vaccine, and far more of that is being supplied internationally than the entirety of doses exported from the EU. I think your 50% figure is also too high, though it is a high proportion, but these doses are primarily going to wealthy countries. If the EU were asking for U.K. doses to be routed to other (particularly poorer) countries I would be sympathetic to the position, but this spat is about getting the EU doses, not about equitable access.